WomensHealthStudyGuide
Feminism
Acknowledges oppression of women within patriarchal society
Work “WITH” as opposed to For
Uses heterogeneity- quality or state of being diverse in character or
content Not Homogeneity- everyone fits into a “box”
Minimizes/ exposes power imbalances
Rejects androcentric models
Challenges medicalization and pathophysiology
Seeks social and political change to address women’s health issues
Health
A state of complete physical, mental, and social well-being and not merely the absence
of disease or infirmity
Research
Evidence Based Practice- Clinical research + Patient Preference + Clinical
Experience
-Help to standardize care or eliminate wide variations in care
-Assists w/ development of outcome based performance measures
-Eliminates unnecessary processes or procedures and sort through research
*Began w/ Nightingale
Randomized Controlled Trial- Considered Gold Standard
Systematic Review- literature review, collects and critically analyzes multiple research
Meta-Analyses- subset of systematic reviews; Qualitative + Quantitative =1
conclusion Quasi-Experimental- treatment and control groups may not be comparable at
baseline Qualitative- researcher cannot be fully removed, “naturalistic”- uncontrolled setting
Questions are often
exploratory Stetler Model of Research
Utilization
Preparation (Purpose?), Validation (examine/critique),
Comparative Evaluation- synthesize evidence and decide whether to use it or not
Translation (dissemination of change), Evaluation (is it working?)
Prevention
Primary= preventing disease in susceptible populations
Secondary= focus on early detection of disease to severity and short and long-term problems
Tertiary= services limit disability and promote rehabilitation from disease states
#1 Preventable Death in US-
Smoking Killers- Cardiac
Cancer (top 3) In Women
Worldwide Breast, Lung, Colorectal
Leading Causes of Cancer Death in
Women Lung, Breast, Colorectal
Leading Cause of Gyn Death
Ovarian
Immunization
MMR, Zoster, Varicella, HPV, MPSV4- CI for pregnancy
,WomensHealthStudyGuide
Tdap in 3rd Trimester of Every Pregnancy
,WomensHealthStudyGuide
Pregnancy Not Attempted Until 28 Days After Rubella Vaccine
Hep B in Risk- 2+ Partners in 6 months, Eval/Tx for STD, IV use
G&D Theories
Erickson’s
Trust/Mistrust =Infancy
Autonomy/Shame= Early Childhood 18 months – 3 years
Initiative/Guilt= Play Age 3-5
Industry/Inferiority= School Age 5-12
Identity/Role Confusion= Adolescence 12-18
Intimacy/Isolation= Young Adult 18-40
Generativity/Stagnation= Adult 40-65
Ego Integrity/Despair= Maturity 65+
Tanner Stages
Stage 1- Prepubertal (Vellus Hair- No Pubic)
Stage 2- Breast bud stage w/ elevation of breast and papilla; enlarged areola
Thelarche (8-13) and Menarche is 1-3 Years Later
Adrenarche ~6 months After Thelarche
Sparse, long, slightly pigmented, straight or slightly
curved Mean age- 12.1 = undetectable estradiol to
24
Stage 3- Further enlargement, no separation of contour
Darker, coarser, curlier, sparsely over pubic symphysis
Mean age- 13.6 = undetectable estradiol to 60
Stage 4- Secondary Mound and Menarche typically (9-17)
Coarse and curly, covered greatly, but not including the thighs
Mean age- 15.1 = estradiol 15-85
Stage 5- Mature- projection of papilla only; Hair adult in quantity and quality
Mean age- 18 = estradiol 15-350
Screening
All Women- Depression (women at risk), ask about mood and ADL pleasure
IPV, BMI (25-29.9= overweight), HTN, Rubella Immunity, Tobacco Use
Ovarian Cancer- risks w/ screening outweighs benefits, family history BRCA1 BRCA2 How
to screen for BRCA?
Adolescents- #1 Chlamydia (sexually active 24 and younger)
Chlamydia and Gonorrhea – Nucleic acid amplification test (NAAT) recommended
Middle age & Older
Breast Ca- 50-74- Mammogram Q2
Colorectal- 50+, FOBT Q1, Sigmoid q5 or Colonoscopy
q10 Cholesterol- 45+
Older Women- hearing, visual
changes Osteoporosis- 60+
DEXA Q2
Menstrual Cycle
Hypothalamus, Anterior Pituitary, Ovaries, Uterus, Outflow
, WomensHealthStudyGuide
Tract
Caucasian- 12.6; AA- 12.1; Latinas 12.2
Feminism
Acknowledges oppression of women within patriarchal society
Work “WITH” as opposed to For
Uses heterogeneity- quality or state of being diverse in character or
content Not Homogeneity- everyone fits into a “box”
Minimizes/ exposes power imbalances
Rejects androcentric models
Challenges medicalization and pathophysiology
Seeks social and political change to address women’s health issues
Health
A state of complete physical, mental, and social well-being and not merely the absence
of disease or infirmity
Research
Evidence Based Practice- Clinical research + Patient Preference + Clinical
Experience
-Help to standardize care or eliminate wide variations in care
-Assists w/ development of outcome based performance measures
-Eliminates unnecessary processes or procedures and sort through research
*Began w/ Nightingale
Randomized Controlled Trial- Considered Gold Standard
Systematic Review- literature review, collects and critically analyzes multiple research
Meta-Analyses- subset of systematic reviews; Qualitative + Quantitative =1
conclusion Quasi-Experimental- treatment and control groups may not be comparable at
baseline Qualitative- researcher cannot be fully removed, “naturalistic”- uncontrolled setting
Questions are often
exploratory Stetler Model of Research
Utilization
Preparation (Purpose?), Validation (examine/critique),
Comparative Evaluation- synthesize evidence and decide whether to use it or not
Translation (dissemination of change), Evaluation (is it working?)
Prevention
Primary= preventing disease in susceptible populations
Secondary= focus on early detection of disease to severity and short and long-term problems
Tertiary= services limit disability and promote rehabilitation from disease states
#1 Preventable Death in US-
Smoking Killers- Cardiac
Cancer (top 3) In Women
Worldwide Breast, Lung, Colorectal
Leading Causes of Cancer Death in
Women Lung, Breast, Colorectal
Leading Cause of Gyn Death
Ovarian
Immunization
MMR, Zoster, Varicella, HPV, MPSV4- CI for pregnancy
,WomensHealthStudyGuide
Tdap in 3rd Trimester of Every Pregnancy
,WomensHealthStudyGuide
Pregnancy Not Attempted Until 28 Days After Rubella Vaccine
Hep B in Risk- 2+ Partners in 6 months, Eval/Tx for STD, IV use
G&D Theories
Erickson’s
Trust/Mistrust =Infancy
Autonomy/Shame= Early Childhood 18 months – 3 years
Initiative/Guilt= Play Age 3-5
Industry/Inferiority= School Age 5-12
Identity/Role Confusion= Adolescence 12-18
Intimacy/Isolation= Young Adult 18-40
Generativity/Stagnation= Adult 40-65
Ego Integrity/Despair= Maturity 65+
Tanner Stages
Stage 1- Prepubertal (Vellus Hair- No Pubic)
Stage 2- Breast bud stage w/ elevation of breast and papilla; enlarged areola
Thelarche (8-13) and Menarche is 1-3 Years Later
Adrenarche ~6 months After Thelarche
Sparse, long, slightly pigmented, straight or slightly
curved Mean age- 12.1 = undetectable estradiol to
24
Stage 3- Further enlargement, no separation of contour
Darker, coarser, curlier, sparsely over pubic symphysis
Mean age- 13.6 = undetectable estradiol to 60
Stage 4- Secondary Mound and Menarche typically (9-17)
Coarse and curly, covered greatly, but not including the thighs
Mean age- 15.1 = estradiol 15-85
Stage 5- Mature- projection of papilla only; Hair adult in quantity and quality
Mean age- 18 = estradiol 15-350
Screening
All Women- Depression (women at risk), ask about mood and ADL pleasure
IPV, BMI (25-29.9= overweight), HTN, Rubella Immunity, Tobacco Use
Ovarian Cancer- risks w/ screening outweighs benefits, family history BRCA1 BRCA2 How
to screen for BRCA?
Adolescents- #1 Chlamydia (sexually active 24 and younger)
Chlamydia and Gonorrhea – Nucleic acid amplification test (NAAT) recommended
Middle age & Older
Breast Ca- 50-74- Mammogram Q2
Colorectal- 50+, FOBT Q1, Sigmoid q5 or Colonoscopy
q10 Cholesterol- 45+
Older Women- hearing, visual
changes Osteoporosis- 60+
DEXA Q2
Menstrual Cycle
Hypothalamus, Anterior Pituitary, Ovaries, Uterus, Outflow
, WomensHealthStudyGuide
Tract
Caucasian- 12.6; AA- 12.1; Latinas 12.2
